FDA Approves ACETAZOLAMIDE — Lifestar Pharma LLC

# FDA Approves Lifestar Pharma's Generic Acetazolamide The U.S. Food and Drug Administration has approved Lifestar Pharma LLC's abbreviated new drug application for generic acetazolamide oral tablets, expanding the competitive landscape in the carbonic anhydrase inhibitor market and potentially lowering costs for patients treating glaucoma, altitude sickness, and other conditions. The approval adds another generic competitor to the acetazolamide market, which could pressure pricing and increase accessibility for this established therapeutic agent.